After a 400% increase in production, NutraCea will expand its Dillon, Montana plant’s capacity for products made from stabilised rice bran derivatives.

The Dillon facility expansion is anticipated to be completed during the second quarter of this year, and should result in a 50% increase in production capability of stabilised rice bran derivative products.

NutraCea COO Ike Lynch said: “Since the NutraCea/RiceX merger closing a few months ago, the company has been consistently utilising at or close to 100% of the manufacturing capacity of its Dillon, Montana facility. This represents an increase of daily average production during the period following the closing of the merger by more than 400% when compared to the average daily production capacity during the nine months prior to the merger.”